Clinical-Stage Biotech Stock Might Outperform Amgen Post author:Sam Post published:February 8, 2018 Post category:BioPharma This biotech could potentially could be a better value. Source: BioSpace You Might Also Like Counsyl Celebrates Anniversary With $80M Funding Round November 6, 2017 AMO Pharma Sees Positive Results in Phase II Trials March 15, 2018 FDA Slaps Clinical Hold on Concert Pharma's Hair Loss Drug May 16, 2017
